Pulmonx Corporation
LUNG
$4.52
-$0.27-5.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -13.18M | -14.14M | -15.33M | -13.75M | -13.89M |
| Total Depreciation and Amortization | 294.00K | -424.00K | 1.20M | 423.00K | 287.00K |
| Total Amortization of Deferred Charges | 11.00K | 811.00K | 931.00K | 16.00K | 13.00K |
| Total Other Non-Cash Items | 5.35M | 5.69M | 6.11M | 6.14M | 5.56M |
| Change in Net Operating Assets | 789.00K | 825.00K | 1.31M | -4.63M | -422.00K |
| Cash from Operations | -6.73M | -7.24M | -5.77M | -11.80M | -8.45M |
| Capital Expenditure | -111.00K | -416.00K | -469.00K | -451.00K | -200.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 14.18M | 7.17M | -366.00K | -2.06M | -2.56M |
| Cash from Investing | 14.07M | 6.75M | -835.00K | -2.51M | -2.76M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -49.00K | 0.00 | -46.00K | -- | -47.00K |
| Issuance of Common Stock | 111.00K | 459.00K | 24.00K | 864.00K | 64.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 62.00K | 459.00K | -22.00K | 864.00K | 17.00K |
| Foreign Exchange rate Adjustments | 193.00K | -119.00K | -46.00K | 48.00K | -210.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.59M | -151.00K | -6.67M | -13.39M | -11.40M |